Anthem Biosciences mutual fund holdings
NSE: ANTHEMBSE: 544449Pharmaceuticals & BiotechnologyMid Cap
Anthem Biosciences Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 2025 · Issue price ₹570
Last close ₹828.80down ₹1.35 (0.16%)BSE ₹828.45
Share price at the NSE close on 30 Oct 2026. Previous close ₹830.15.
30 Oct: open ₹827.00, high ₹845.40, low ₹824.75
52-week range of traded prices to 30 Oct 2026
₹579.15Low, 2 Feb 2026₹977.55High, 9 Sep 2026
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹46,705 Cr226th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 81.09
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 15.35
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.24%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record.
- 18.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 21.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.02
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,50,65153.0% delivered
155 mutual funds from 30 fund houses held Anthem Biosciences at the end of Sep 2026, each fund counted once across its plans: ₹4,476 Cr between them Value held by mutual funds. The market value of every mutual fund's holding of the company at the month's end, added up, as each fund reports it. Value held by mutual funds in the glossary, 9.25% Mutual funds' share of the company. The shares every mutual fund holds at the month's end, added up and divided by the company's shares in issue. Read from the funds' own portfolios, so it can differ from the mutual funds line of the company's quarterly shareholding filing. Mutual funds' share of the company in the glossary of the company's shares.
Mutual funds holding Anthem Biosciences, Sep 2026
Largest holding first.
How many funds hold the company each month, and what their holdings are worth, from each month's portfolio disclosures
- Funds holding it
- Value held, ₹ crore
| Fund | |||
|---|---|---|---|
 HDFC Flexi Cap FundHDFC Mutual Fund | 74,00,111 | 0.59% | ₹635.4 Cr |
 SBI Midcap FundSBI Mutual Fund | 43,18,200 | 1.59% | ₹370.8 Cr |
 Axis ELSS Tax Saver FundAxis Mutual Fund | 29,22,400 | 0.83% | ₹250.9 Cr |
 Aditya Birla Sun Life Flexi Cap FundAditya Birla Sun Life Mutual Fund | 24,50,000 | 0.75% | ₹210.4 Cr |
| SBI MNC FundSBI Mutual Fund | 22,00,000 | 2.96% | ₹188.9 Cr |
| SBI Healthcare Opportunities FundSBI Mutual Fund | 18,80,000 | 2.75% | ₹161.4 Cr |
| Axis Midcap FundAxis Mutual Fund | 18,52,294 | 0.47% | ₹159.0 Cr |
 UTI Mid Cap FundUTI Mutual Fund | 16,00,000 | 1.15% | ₹137.4 Cr |
 Kotak Multi Asset Allocation FundKotak Mahindra Mutual Fund | 15,79,081 | 0.89% | ₹135.6 Cr |
| HDFC Pharma and Healthcare FundHDFC Mutual Fund | 12,91,629 | 3.17% | ₹110.9 Cr |
 Nippon India Pharma FundNippon India Mutual Fund | 12,75,040 | 1.19% | ₹109.5 Cr |
 Mirae Asset Small Cap FundMirae Asset Mutual Fund | 12,41,888 | 1.83% | ₹106.6 Cr |
| Axis Flexi Cap FundAxis Mutual Fund | 11,99,181 | 0.78% | ₹103.0 Cr |
 Mahindra Manulife Mid Cap FundMahindra Manulife Mutual Fund | 11,88,301 | 2.02% | ₹102.0 Cr |
| HDFC Business Cycle FundHDFC Mutual Fund | 11,64,887 | 3.78% | ₹100.0 Cr |
Portfolios disclosed for Sep 2026. Weight is the holding as a share of the fund's assets.
Buying and selling, month by month
How many funds bought for the first time, bought again, added, cut or sold out, against their own previous month.
Funds, by what they did
Largest first-time buy in Sep 2026: Capitalmind Flexi Cap Fund; largest addition: Tata India Pharma & Healthcare Fund.Largest cut in Sep 2026: HDFC Manufacturing fund; largest exit: HDFC Innovation Fund.
Shares held by all funds
- Shares heldShares held by all funds. The shares every mutual fund holding the company reports at the month's end, added up. Shares held by all funds in the glossary
Fund by fund, month by month
| Fund | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HDFC Flexi Cap FundHDFC Mutual Fund | – | – | – | – | – | 75,75,000Bought | 75,75,000 | 75,75,000 | 83,27,643+7,52,643 (+9.9%) | 83,27,643 | 77,65,558−5,62,085 (−6.8%) | 74,00,111−3,65,447 (−4.7%) |
| SBI Midcap FundSBI Mutual Fund | – | – | – | – | – | 32,40,200Bought | 32,40,200 | 32,40,200 | 43,18,200+10,78,000 (+33.3%) | 43,18,200 | 43,18,200 | 43,18,200 |
| Axis ELSS Tax Saver FundAxis Mutual Fund | 14,40,566 | 14,40,566 | 14,40,566 | 14,40,566 | 15,15,215+74,649 (+5.2%) | 24,28,783+9,13,568 (+60.3%) | 25,00,485+71,702 (+3.0%) | 25,00,485 | 25,00,485 | 29,22,400+4,21,915 (+16.9%) | 29,22,400 | 29,22,400 |
| Aditya Birla Sun Life Flexi Cap FundAditya Birla Sun Life Mutual Fund | – | – | – | – | – | 25,21,979Bought | 25,21,979 | 24,50,000−71,979 (−2.9%) | 24,50,000 | 24,50,000 | 24,50,000 | 24,50,000 |
| SBI MNC FundSBI Mutual Fund | 16,00,000 | 17,00,000+1,00,000 (+6.3%) | 17,00,000 | 18,00,000+1,00,000 (+5.9%) | 20,00,000+2,00,000 (+11.1%) | 23,61,990+3,61,990 (+18.1%) | 23,62,555+565 (0.0%) | 22,02,469−1,60,086 (−6.8%) | 22,99,000+96,531 (+4.4%) | 23,20,000+21,000 (+0.9%) | 23,20,000 | 22,00,000−1,20,000 (−5.2%) |
| SBI Healthcare Opportunities FundSBI Mutual Fund | 12,00,000 | 13,00,000+1,00,000 (+8.3%) | 13,00,000 | 14,00,000+1,00,000 (+7.7%) | 15,59,811+1,59,811 (+11.4%) | 19,61,996+4,02,185 (+25.8%) | 19,62,504+508 (0.0%) | 18,02,207−1,60,297 (−8.2%) | 18,40,000+37,793 (+2.1%) | 18,80,000+40,000 (+2.2%) | 18,80,000 | 18,80,000 |
| Axis Midcap FundAxis Mutual Fund | 6,51,139 | 6,51,139 | 6,51,139 | 6,51,139 | 6,51,139 | 7,36,299+85,160 (+13.1%) | 15,63,383+8,27,084 (+112.3%) | 15,63,383 | 15,63,383 | 17,29,118+1,65,735 (+10.6%) | 18,52,294+1,23,176 (+7.1%) | 18,52,294 |
| UTI Mid Cap FundUTI Mutual Fund | – | – | – | – | – | – | 4,70,000Bought | 4,70,000 | 12,55,538+7,85,538 (+167.1%) | 21,79,977+9,24,439 (+73.6%) | 20,00,000−1,79,977 (−8.3%) | 16,00,000−4,00,000 (−20.0%) |
| Kotak Multi Asset Allocation FundKotak Mahindra Mutual Fund | – | – | – | – | – | – | – | – | 13,42,643Bought | 15,79,081+2,36,438 (+17.6%) | 15,79,081 | 15,79,081 |
| HDFC Pharma and Healthcare FundHDFC Mutual Fund | 9,68,972+1,58,159 (+19.5%) | 12,32,728+2,63,756 (+27.2%) | 12,32,728 | 12,66,228+33,500 (+2.7%) | 12,91,629+25,401 (+2.0%) | 12,91,629 | 12,91,629 | 12,91,629 | 12,91,629 | 12,91,629 | 12,91,629 | 12,91,629 |
| Nippon India Pharma FundNippon India Mutual Fund | 10,58,503 | 10,58,503 | 10,58,503 | 10,58,503 | 10,58,503 | 10,58,503 | 10,58,503 | 10,58,503 | 10,58,503 | 10,58,503 | 12,75,040+2,16,537 (+20.5%) | 12,75,040 |
| Mirae Asset Small Cap FundMirae Asset Mutual Fund | 1,59,582+97,622 (+157.6%) | 3,69,559+2,09,977 (+131.6%) | 5,27,332+1,57,773 (+42.7%) | 5,27,332 | 5,91,601+64,269 (+12.2%) | 9,71,662+3,80,061 (+64.2%) | 12,71,662+3,00,000 (+30.9%) | 12,32,113−39,549 (−3.1%) | 12,41,888+9,775 (+0.8%) | 12,41,888 | 12,41,888 | 12,41,888 |
| Axis Flexi Cap FundAxis Mutual Fund | – | – | – | – | – | 8,31,858Bought | 8,31,858 | 11,99,181+3,67,323 (+44.2%) | 11,99,181 | 11,99,181 | 11,99,181 | 11,99,181 |
| Mahindra Manulife Mid Cap FundMahindra Manulife Mutual Fund | 11,07,065+1,00,000 (+9.9%) | 11,07,065 | 11,07,065 | 11,07,065 | 11,07,065 | 12,72,301+1,65,236 (+14.9%) | 12,72,301 | 12,72,301 | 12,72,301 | 12,72,301 | 12,72,301 | 11,88,301−84,000 (−6.6%) |
| HDFC Business Cycle FundHDFC Mutual Fund | 13,35,040 | 13,35,040 | 13,35,040 | 13,35,040 | 13,35,040 | 13,35,040 | 13,35,040 | 13,35,040 | 13,35,040 | 13,35,040 | 13,35,040 | 11,64,887−1,70,153 (−12.8%) |
Shares held at each month end. Under them, the change on the fund's previous month; a fund that files only weights shows the word. “After a gap” is a fund holding it after a month with no portfolio on record, so when it bought is not known; “Not filed” is one gone across such a gap.